Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Amiot

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Annales De Dermatologie Et De Venereologie|November 26, 2025
Neoadjuvant ipilimumab and nivolumab for resectable stage II mucosal melanomaM Amiot, C Halimi, A Chaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Cancer Research|August 15, 1995
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalizationC Pellat-Deceunynck, S Barillé, D Puthier, et al.
Blood|November 15, 1995
Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years afterCatherine Pellat-Deceunynck, M Amiot, R Bataille, et al.
British Journal of Haematology|August 25, 1999
CD130 rather than CD126 expression is associated with disease activity in multiple myelomaS Barillé, W Thabard, N Robillard, et al.
Cell Death & Disease|August 29, 2014
Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIKC Brosseau, C Dousset, C Touzeau, et al.
Leukemia|August 30, 2002
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cellsS Le Gouill, C Pellat-Deceunynck, J-L Harousseau, et al.
British Journal of Haematology|November 1, 1995
High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cellsN Juge-Morineau, M P Mellerin, S Francois, et al.
Leukemia Research|June 27, 2000
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSFG Jego, H Avet-Loiseau, N Robillard, et al.
Blood|August 15, 1997
Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cellsS Barillé, C Akhoundi, M Collette, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Annales De Dermatologie Et De Venereologie|November 26, 2025
Neoadjuvant ipilimumab and nivolumab for resectable stage II mucosal melanomaM Amiot, C Halimi, A Chaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Cancer Research|August 15, 1995
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalizationC Pellat-Deceunynck, S Barillé, D Puthier, et al.
Blood|November 15, 1995
Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years afterCatherine Pellat-Deceunynck, M Amiot, R Bataille, et al.
British Journal of Haematology|August 25, 1999
CD130 rather than CD126 expression is associated with disease activity in multiple myelomaS Barillé, W Thabard, N Robillard, et al.
Cell Death & Disease|August 29, 2014
Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIKC Brosseau, C Dousset, C Touzeau, et al.
Leukemia|August 30, 2002
Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cellsS Le Gouill, C Pellat-Deceunynck, J-L Harousseau, et al.
British Journal of Haematology|November 1, 1995
High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cellsN Juge-Morineau, M P Mellerin, S Francois, et al.
Leukemia Research|June 27, 2000
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSFG Jego, H Avet-Loiseau, N Robillard, et al.
Blood|August 15, 1997
Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cellsS Barillé, C Akhoundi, M Collette, et al.
Pageof 8